TrialEuropean radiology2022

CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapy.

Fengchang Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.